Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

Nature Genetics

Volumn 17, Issue 3, 1997, Pages 314-317

  Kafri, Tal ^a   Blömer, Ulrike ^a   Peterson, Daniel A ^a   Gage, Fred H ^a   Verma, Inder M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; LIVER; MOLONEY LEUKEMIA ONCOVIRUS; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV; HUMANS; INFLAMMATION; LENTIVIRUS; LIVER; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MOLONEY MURINE LEUKEMIA VIRUS; MUSCLES; RATS; RATS, INBRED F344; RATS, NUDE; VIRAL ENVELOPE PROTEINS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LEUKAEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; VESICULAR STOMATITIS VIRUS;

EID: 0030716959     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1197-314     Document Type: Article

References (21)

1. Mulligan, R.C. The basic science of gene therapy. Science 260, 926-932 (1993).
2. Crystal, R.G. Transfer of genes to humans: early lessons and obstacles to success. Science 270, 404-410 (1995).
3. Leiden, J.M. Gene therapy - promises, pitfalls and prognosis. N. Engl. J. Med. 333, 871-673 (1995).
4. Verma, I.M. & Somia, N. Gene therapy: promises, problems and prospects. Nature 389, 239-242 (1997).
5. Maldini, L., Blomer, U., Gage, F., Trono, D. & Verma, I. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388 (1996).
6. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
7. Blömer, U. et al. Highly efficient and sustained gene transfer in adult neurons with a lentiviral vector. J. Virol. 71, 6641-6649 (1997).
8. Burns, J.C., Friedman, T., Driever, W., Burrascano, M. & Yii, J.-K. Vesicular stomatitis virus G protein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037 (1993).
9. Miyoshi, H., Takahashi, M., Gage, F.H. & Verma, I.M. Stable and efficient gene transfer into the retina using a lentiviral vector. Proc. Natl. Acad. Sci. USA 94, 10319-10323 (1997).
10. Peterson, D.A., Lucidi-Phillipi, C.A., Eagle, K.L. & Gage, F.H. Perforant path damage results in progressive neuronal death and somal atrophy in layer II of entorhinal cortex and functional impairment with increasing post-damage age. J. Neurosci. 14, 6872-6885 (1994).
11. Barr, E. & Leiden, J.M. Systemic delivery of recombinant proteins by genetically modified myoplasts. Science 254, 1507-1509 (1991).
12. Dhawan, J. et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512 (1991).
13. Dai, Y., Roman, M., Naviaux, R.K. & Verma, I.M. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895 (1992).
14. Dai, Y. et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405 (1995).
15. Palmer, T.D., Rosman, G.J., Osborne, W.R.A. & Miller, A.D. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334 (1991).
16. Scharfmann, R., Axelrod, J.H. & Verma, I.M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-4630 (1991).
17. Yang, Y., Ertl, J. & Wilson, J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442 (1994).
18. Yang, Y., Li, Q., Ertl, H. & Wilson, J. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
19. Gibbs, J.S., Regier, D.A. & Desrosiers, R.C. Construction and in vitro properties of HIV-1 mutants with deletions in "non-essential" genes. AIDS Res. Hum. Retroviruses 10, 343-350 (1994).
20. Hattori, N. et al. The human immunodeficiency virus type 2 Vpr genes is essential for productive infection of human macrophages. Proc Natl. Acad. Sci. USA 87, 8080-8084 (1990).
21. Heinzinger, N.K. et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315 (1994).